Interventions for oral candidiasis in HIV positive patients
Interventions for oral candidiasis in HIV positive patients
Cochrane Review
7 SoF Entries
Summary of Findings
Key results and quality assessments using GRADE methodology
| Outcome | Effect | Participants | Studies | Certainty |
|---|---|---|---|---|
|
HbA1c (3-4 months follow-up)
Usual care/no active treatment |
-0.29 | - | - | Not assessed |
|
Adverse effects
Usual care/no active treatment |
nan | - | - | Not assessed |
|
HbA1c after 3/4 months
no treatment/usual treatment |
-0.4 | - | - | Not assessed |
|
CAL after 3/4 months
no treatment/usual treatment |
-0.07 | - | - | Not assessed |
|
PD after 3/4 months
no treatment/usual treatment |
-0.39 | - | - | Not assessed |
|
BOP after 3/4 months
no treatment/usual treatment |
-20.21 | - | - | Not assessed |
|
HbA1c (3 to 4 months follow-up)
no active treatment/usual care |
-0.43 | - | - | Not assessed |
GRADE Certainty of Evidence:
High
Very confident in the effect estimate
Moderate
Moderately confident in the effect estimate
Low
Limited confidence in the effect estimate
Very Low
Very little confidence in the effect estimate
Review Information
| Review ID: | CD004714 |
| Outcomes: | 7 assessed |
Related Content
Evidence Quality Distribution:
Not assessed:
7